- Home
- PRZO vs MYNZ Comparison
PRZO vs MYNZ Comparison
Compare PRZO & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- MYNZ
- Stock Information
- Founded
- PRZO 2014
- MYNZ 2021
- Country
- PRZO Israel
- MYNZ Germany
- Employees
- PRZO N/A
- MYNZ N/A
- Industry
- PRZO
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- MYNZ Health Care
- Exchange
- PRZO Nasdaq
- MYNZ Nasdaq
- Market Cap
- PRZO 15.1M
- MYNZ 16.0M
- IPO Year
- PRZO 2023
- MYNZ 2021
- Fundamental
- Price
- PRZO $1.17
- MYNZ $5.74
- Analyst Decision
- PRZO
- MYNZ Buy
- Analyst Count
- PRZO 0
- MYNZ 3
- Target Price
- PRZO N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- PRZO 803.9K
- MYNZ 361.6K
- Earning Date
- PRZO 03-26-2025
- MYNZ 04-15-2025
- Dividend Yield
- PRZO N/A
- MYNZ N/A
- EPS Growth
- PRZO N/A
- MYNZ N/A
- EPS
- PRZO N/A
- MYNZ N/A
- Revenue
- PRZO $558,382.00
- MYNZ $917,203.00
- Revenue This Year
- PRZO N/A
- MYNZ $21.95
- Revenue Next Year
- PRZO N/A
- MYNZ $30.77
- P/E Ratio
- PRZO N/A
- MYNZ N/A
- Revenue Growth
- PRZO N/A
- MYNZ 16.23
- 52 Week Low
- PRZO $0.49
- MYNZ $0.18
- 52 Week High
- PRZO $3.16
- MYNZ $8.20
- Technical
- Relative Strength Index (RSI)
- PRZO 33.12
- MYNZ 48.77
- Support Level
- PRZO $1.12
- MYNZ $5.08
- Resistance Level
- PRZO $1.49
- MYNZ $8.16
- Average True Range (ATR)
- PRZO 0.13
- MYNZ 1.10
- MACD
- PRZO -0.05
- MYNZ -0.23
- Stochastic Oscillator
- PRZO 6.94
- MYNZ 21.15
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.